» Articles » PMID: 17913433

Detecting Blastocystis Using Parasitologic and DNA-based Methods: a Comparative Study

Overview
Date 2007 Oct 5
PMID 17913433
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Few studies have targeted the relative performance of diagnostic methods used for the detection of Blastocystis, a unicellular organism often present in fecal specimens from individuals with and without gastrointestinal symptoms. Aims of this study included a comparison of the formol ethyl acetate concentration technique (FECT), permanent trichrome staining of feces fixed in sodium acetate-acetic acid-formalin (SAF-PST), xenic in vitro culture (XIVC), and polymerase chain reaction (PCR) regarding Blastocystis screening of 107 samples from 93 patients with suspected enteroparasitic disease. Compared with PCR, the sensitivity/specificity of XIVC, SAF-PST, and FECT was 89%/100%, 82%/100%, and 50%/100%, respectively. False-negative results generated by the FECT and SAF-PST appeared to be associated with Blastocystis sp. subtype 3. A comparison of results obtained by dideoxy sequencing of positive PCR products amplified from DNA extracted directly from feces and DNA extracted from 5- and 28-day-old XIVC of 10 randomly chosen Blastocystis isolates showed no disparities, indicating that XIVC has very little or no impact on subtype distribution or variation within a given specimen. It is recommended that short-term XIVC be used for cost-effective screening of fresh fecal specimens for Blastocystis infection to generate valid prevalence estimates and to identify isolates for molecular characterization in studies aiming to illuminate the molecular epidemiology of Blastocystis.

Citing Articles

Genetic diversity of single-celled microorganism sp. and its associated gut microbiome in free-ranging marine mammals from North-Western Mediterranean Sea.

Marangi M, Boughattas S Curr Res Microb Sci. 2025; 8:100349.

PMID: 39926158 PMC: 11803257. DOI: 10.1016/j.crmicr.2025.100349.


Blastocystis hominis; Friend or Foe.

Guard G Integr Med (Encinitas). 2024; 23(5):28-33.

PMID: 39534663 PMC: 11552959.


Unveiling Blastocystis epidemiology in Morocco: subtype diversity among clinical patients with and without gastrointestinal manifestations in the Meknes region.

Boutahar M, Belaouni M, Ibrahimi A, Eljaoudi R, Aanniz T, Er-Rami M Parasitol Res. 2024; 123(7):273.

PMID: 39017986 DOI: 10.1007/s00436-024-08288-w.


Subtype Distribution of spp. in Patients with Gastrointestinal Symptoms in Northern Spain.

Matovelle C, Quilez J, Tejedor M, Beltran A, Chueca P, Monteagudo L Microorganisms. 2024; 12(6).

PMID: 38930466 PMC: 11205523. DOI: 10.3390/microorganisms12061084.


The influence of plant extracts on viability of ST3 and ST7 subtypes of Blastocystis sp.

Kot K, Michaliszyn A, Kalisinska E, Lepczynska M Gut Pathog. 2024; 16(1):19.

PMID: 38570865 PMC: 10988960. DOI: 10.1186/s13099-024-00613-z.